‘Symptom science’ aims to ease burden of cancer treatment
April 09, 2024
Team of OHSU researchers working to discover better ways to control cancer symptoms, toxic side effects of treatments to improve quality of life for people battling cancer.
OHSU Match Day 2024: A career-defining moment for soon-to-be physicians
March 15, 2024
M.D. Class of 2024 achieves a 99% placement rate; OHSU residency programs post 99% fill rate.
Match Day de OHSU 2024: un momento decisivo para la carrera de los futuros médicos
March 15, 2024
La clase de Doctores en Medicina de 2024 logra una tasa de colocación del 99%; los programas de residencia de OHSU alcanzan una tasa de ocupación del 99%.
OHSU Knight Cancer Institute announces leadership transition
March 14, 2024
Amid continued growth, longtime director Brian Druker, M.D., will become CEO; Tom Sellers, Ph.D., M.P.H., will take on director role.
Research sheds light on new strategy to treat infertility
March 08, 2024
OHSU scientists advance technique to turn a skin cell into an egg; could help same-sex couples, others have children genetically related to both parents.
OHSU offers new treatment for deadly skin cancer
March 05, 2024
OHSU Knight Cancer Institute only provider in the region to offer TIL therapy for late-stage melanoma; holds promise for other types of cancer.
OHSU ofrece un nuevo tratamiento para un tipo mortal de cáncer de piel
March 05, 2024
OHSU Knight Cancer Institute es el único centro médico de la región que ofrece la terapia TIL como tratamiento para el melanoma en estadio avanzado; panorama prometedor para otros tipos de cáncer.
OHSU is a ‘top producer’ of Fulbright scholars
February 13, 2024
Three researchers have traveled abroad for the academic year to help address global challenges.
Científicos de OHSU recibieron fondos para extender investigación de vanguardia
February 06, 2024
Científicos de OHSU recibieron fondos para extender investigación de vanguardia.
OHSU scientists awarded funding to extend leading-edge research
February 06, 2024
Projects will involve unique approaches to neuroimaging, mapping neural circuits, ‘oncoGPT’ for cancer.